Physician

Brian A Mannion, M.D.

According to 2025 Medicare claims, Brian Mannion, M.D. (NPI: 1851387039) practices hematology/oncology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is CHRIST HOSPITAL MEDICAL SPECIALISTS II, LLC (NPI: 1891065256; TIN: 452681845) and primary practice location at 45249-2309. Mannion is affiliated with the Healthcare Solutions Network (ACO ID: A3283) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Mannion's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 459 traditional Medicare patients, billed 75,078 HCPCS/CPT codes, and received $1,554,316 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,833 prescription claims across 277 beneficiaries totaling $5,314,737 in drug costs, led by Cabometyx (Cabozantinib S-Malate). 2021 DME data shows 11 claims. Open Payments data shows 3 records totaling $141. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $2,106,841 to $1,554,316. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,759,337 to $5,314,737. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $14,668 to $1,536.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	439	142,798	$2,106,841
2016	521	157,274	$2,565,702
2017	487	162,513	$2,705,048
2018	509	142,189	$2,436,069
2019	507	152,775	$2,092,796
2020	459	168,056	$2,355,014
2021	478	138,019	$2,378,046
2022	468	118,879	$1,538,985
2023	482	116,203	$2,135,673
2024	459	75,078	$1,554,316

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	203	1,723	$2,759,337
2016	208	1,678	$3,266,984
2017	242	1,871	$3,592,418
2018	251	1,808	$4,086,167
2019	248	1,720	$4,915,397
2020	239	1,803	$6,068,604
2021	278	1,840	$6,133,837
2022	243	1,755	$6,200,598
2023	264	1,938	$5,767,887
2024	277	1,833	$5,314,737

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	28	220	$29,947
2016	N/R	79	$5,284
2017	N/R	37	$3,887
2018	N/R	22	$3,362
2019	N/R	12	$3,172
2020	N/R	N/R	N/R
2021	N/R	11	$459
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	125	370	$129
96413	Administration of chemotherapy into vein, 1 hour or less	53	203	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	248	478	$82
80053	Blood test, comprehensive group of blood chemicals	53	149	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	171	589	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cabometyx	Cabozantinib S-Malate	20	600	$519,529
Pomalyst	Pomalidomide	22	616	$513,760
Lenalidomide	Lenalidomide	42	1,087	$511,739
Erleada	Apalutamide	33	990	$498,479
Welireg	Belzutifan	13	390	$387,551

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$141	Incyte Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian A. Mannion, M.D.?

Tedicare shows public-source Medicare data for Brian A. Mannion, M.D. (NPI 1851387039), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian A. Mannion, M.D. have ACO affiliation data?

Brian A. Mannion, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Brian A. Mannion, M.D.?

Brian A. Mannion, M.D. is linked to CHRIST HOSPITAL MEDICAL SPECIALISTS II, LLC (billing NPI 1891065256) in the available physician profile data.

Does Brian A. Mannion, M.D. have Open Payments data?

Brian A. Mannion, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.